Company Overview

Kayla Therapeutics is a biopharmaceutical company focused on developing innovative therapies for a range of diseases. Our mission is to improve the lives of patients by delivering groundbreaking treatments that address unmet medical needs. With a dedicated team of researchers and scientists, we are committed to advancing the field of biotechnology and transforming the way healthcare is delivered.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

3 Patents

#3 in L'Union

#4,038 in France

L'Union, France

Kayla Therapeutics

Forward Citations = 2

3 inventors:

Fabienne Vernejoul (3 out of 9 patents)

Gerard Tiraby (3 out of 11 patents)

Thierry Lioux (3 out of 8 patents)

4. Gérard Tiraby (2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kayla Therapeutics. Retrieved from https://idiyas.com/company/kayla-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]